|3 Months Ended
Mar. 31, 2023
|Subsequent Events [Abstract]
17. Subsequent Events
On May 3, 2023, an additional 60,000,000 ordinary shares of $0.01 par value each were authorized by the shareholders at our 2023 Annual General Meeting of Shareholders (2023 Annual Meeting). In addition, we asked our shareholders to renew the authorization of our board of directors to issue shares and the disapplication of statutory preemption rights at our 2023 Annual Meeting, and to extend that authorization to the increase in authorized share capital that was approved. Our shareholders renewed the authorization of our board of directors to issue shares; however, although we received over 61% support of the votes cast on renewing the pre-emption rights opt-out authority, we did not receive the affirmative vote of at least 75% of the votes cast as required under Irish law for the passing of special resolutions.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef